Skip to main content

Artidis joins world’s largest medical center

| News

Artidis joins world’s largest medical center


The Basel-based startup Artidis is developing a medical device based on nanotechnology to help with cancer diagnoses. The spin-off from the University of Basel has now been successfully integrated in the Texas Medical Center and will therefore have access to the US market.

The team of Artidis, a spin off from the University of Basel (Photo: Artidis)

In a press release, the University of Basel describes the Texas Medical Center (TMC) as the “world’s largest medical center”. Its capacities in the life sciences sector are complemented by the expertise of companies that qualify for the TMC Innovation Accelerator. This year, a total of 140 startups applied to join the international cohort of medical devices, with 16 ultimately proving successful. Artidis, a spin-off from the University of Basel, was one of the successful applicants.

Artidis, which was formed from a research group comprising the University of Basel and the Swiss Nanoscience Institute, has used its proprietary nanotechnology platform in order to develop “the first nanomechanical biomarker for cancer diagnosis and treatment optimization”. The platform integrates different types of clinical data, allowing current diagnostic processes to be shortened and personalized plans for cancer treatment to be produced. As part of the TMC, Artidis can now launch this technology on the US market. “Being part of the TMC Innovation Accelerator program is a great opportunity for us as it provides access to a unique environment at the forefront of science and innovation – the best place to take patient care to the next level”, says Marija Plodinec, CEO of Artidis, in the press release. has also recognized the potential of Artidis. In this regard, the startup has taken part in the location marketing organization’s Venture Mentoring program.

Share this article

Sign up to receive our newsletter in your inbox.

You might also be interested in

Nouscom secures 67.5 million euros in financing

Biotech company Nouscom has raised 67.5 million euros in a series C financing round. The Basel-based firm intends to use...
Read More

Celebrating six months of innovation: i4Challenge accelerator New Ideas 2022/2023

On the 5th of July 2023, the 3rd iteration of the i4Challenge accelerator program New Ideas came to its conclusion....
Read More

How open innovation in healthtech hubs is fueling the rise of digital healthcare

How the ever-increasing uptake of digital solutions is enhancing patient engagement, increasing access to care and lowering the cost of...
Read More

Paradigm shift in pain management

Pain is a crucial sensation for survival, but it can also drive us to depression and long-term suffering if not...
Read More

BOOM Summit in Basel accelerates health technology

The BOOM Summit at Messe Basel in April 2024 will be a completely new kind of healthcare conference. The first...
Read More

Investors stump up 3.7 million Swiss francs in Onena Medicines

Onena Medicines has secured an investment of 3.7 million Swiss francs. The portfolio company of the biotech startup incubator BaseLaunch...
Read More

Do you have a question? We'd like to hear from you.